X

DIFFERIN CREAM 0.1%

Product Information

Registration Status: Active

SIN11116P

DIFFERIN CREAM 0.1% is approved to be sold in Singapore with effective from 1999-09-16. It is marketed by GALDERMA SINGAPORE PTE LTD, with the registration number of SIN11116P.

This product contains Adapalene 0.10% in the form of CREAM. It is approved for TOPICAL use.

This product is manufactured by LABORATOIRES GALDERMA in FRANCE.

It is a has been granted the exemption for supply without a presciption if it met certain criteria.

Reclassified Info

Product Reference
Loading...


Description

Adapalene is a topical retinoid primarily used in the treatment of acne and is also used (off-label) to treat keratosis pilaris as well as other skin conditions. It is currently marketed by Galderma under the trade names Differin in some countries, and Adaferin in India.

Indication

For the topical treatment of comedo, papular and pustular acne (acne vulgaris) of the face, chest or back.

Mechanism of Action

Mechanistically, adapalene binds to specific retinoic acid nuclear receptors (gamma and beta) and retinoid X receptors but does not bind to the cytosolic receptor protein. Although the exact mode of action of adapalene is unknown, it is suggested that topical adapalene may normalize the differentiation of follicular epithelial cells resulting in decreased microcomedone formation.

Pharmacokinetics

Absorption
Absorption of adapalene through human skin is low. Only trace amounts (
Distribution
Metabolism
Metabolized mainly by O-demethylation, hydroxylation and conjugation, and excretion is primarily by the biliary route.
Elimination

Toxicity

The acute oral toxicity of adapalene in mice and rats is greater than 10 mL/kg. Chronic ingestion of the drug may lead to the same side effects as those associated with excessive oral intake of Vitamin A.

Active Ingredient/Synonyms

6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid | Adaferin | Adapaleno | Adapalenum | Differine | Adapalene |


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank

Pharmfair.com uses cookies to improve your browsing experience. We'll assume you're ok with this, but you can opt-out if you wish. Peace!